Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease

Yao-jong Yang, Yen Hsuan Ni

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Huge amount microorganisms resides in human intestine, and many contribute to the maturation and homeostasis of immune system. The diversity of gut ecology are affected by the gestational age, delivery type, feeding sources, and antibiotics use in neonates. Recent studies pointed out that disturbance of gut microbiota, so called dysbiosis, could result in several pediatric diseases including obesity, non-alcoholic fatty liver disease (NAFLD), metabolic syndromes, allergic diseases, and inflammatory bowel diseases. However, there are no single species can be proven to play a key factor in pediatric obesity and NAFLD at present. Various probiotics may confer benefit to these gut microbiota-related pediatric diseases. The clinical application is still limited. This review article aimed to elucidate evidently the relationship between gut microbiota and pediatric obesity/NAFLD and to discuss the potential probiotics use in pediatric obesity and NAFLD.

Original languageEnglish
Pages (from-to)S55-S61
JournalJournal of the Formosan Medical Association
Volume118
DOIs
Publication statusPublished - 2019 Mar 1

Fingerprint

Pediatric Obesity
Probiotics
Dysbiosis
Pediatrics
Ecology
Inflammatory Bowel Diseases
Gestational Age
Intestines
Immune System
Homeostasis
Obesity
Anti-Bacterial Agents
Gastrointestinal Microbiome
Non-alcoholic Fatty Liver Disease

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{17a1049fcf7648908eb841f1cf0778e7,
title = "Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease",
abstract = "Huge amount microorganisms resides in human intestine, and many contribute to the maturation and homeostasis of immune system. The diversity of gut ecology are affected by the gestational age, delivery type, feeding sources, and antibiotics use in neonates. Recent studies pointed out that disturbance of gut microbiota, so called dysbiosis, could result in several pediatric diseases including obesity, non-alcoholic fatty liver disease (NAFLD), metabolic syndromes, allergic diseases, and inflammatory bowel diseases. However, there are no single species can be proven to play a key factor in pediatric obesity and NAFLD at present. Various probiotics may confer benefit to these gut microbiota-related pediatric diseases. The clinical application is still limited. This review article aimed to elucidate evidently the relationship between gut microbiota and pediatric obesity/NAFLD and to discuss the potential probiotics use in pediatric obesity and NAFLD.",
author = "Yao-jong Yang and Ni, {Yen Hsuan}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jfma.2018.11.006",
language = "English",
volume = "118",
pages = "S55--S61",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Excerpta Medica Asia Ltd.",

}

Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease. / Yang, Yao-jong; Ni, Yen Hsuan.

In: Journal of the Formosan Medical Association, Vol. 118, 01.03.2019, p. S55-S61.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease

AU - Yang, Yao-jong

AU - Ni, Yen Hsuan

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Huge amount microorganisms resides in human intestine, and many contribute to the maturation and homeostasis of immune system. The diversity of gut ecology are affected by the gestational age, delivery type, feeding sources, and antibiotics use in neonates. Recent studies pointed out that disturbance of gut microbiota, so called dysbiosis, could result in several pediatric diseases including obesity, non-alcoholic fatty liver disease (NAFLD), metabolic syndromes, allergic diseases, and inflammatory bowel diseases. However, there are no single species can be proven to play a key factor in pediatric obesity and NAFLD at present. Various probiotics may confer benefit to these gut microbiota-related pediatric diseases. The clinical application is still limited. This review article aimed to elucidate evidently the relationship between gut microbiota and pediatric obesity/NAFLD and to discuss the potential probiotics use in pediatric obesity and NAFLD.

AB - Huge amount microorganisms resides in human intestine, and many contribute to the maturation and homeostasis of immune system. The diversity of gut ecology are affected by the gestational age, delivery type, feeding sources, and antibiotics use in neonates. Recent studies pointed out that disturbance of gut microbiota, so called dysbiosis, could result in several pediatric diseases including obesity, non-alcoholic fatty liver disease (NAFLD), metabolic syndromes, allergic diseases, and inflammatory bowel diseases. However, there are no single species can be proven to play a key factor in pediatric obesity and NAFLD at present. Various probiotics may confer benefit to these gut microbiota-related pediatric diseases. The clinical application is still limited. This review article aimed to elucidate evidently the relationship between gut microbiota and pediatric obesity/NAFLD and to discuss the potential probiotics use in pediatric obesity and NAFLD.

UR - http://www.scopus.com/inward/record.url?scp=85057469847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057469847&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2018.11.006

DO - 10.1016/j.jfma.2018.11.006

M3 - Review article

C2 - 30509561

AN - SCOPUS:85057469847

VL - 118

SP - S55-S61

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

ER -